Psychedelic Science 2023

Be Part of

        the Breakthrough

Presented by

Considering psychedelic therapy for adolescents


Considering psychedelic therapy for adolescents

This session explores viewpoints around the potential for psychedelic-assisted therapies to treat adolescents. Today, adolescents are using prescribed substances such as ketamine to address treatment resistant depression. Soon, the FDA may require sponsors of approved psychedelic medications to conduct additional studies with adolescents. Historically, children have ingested age-appropriate doses of plant medicines in ceremonial contexts within indigenous communities. While these treatments are promising, they must carefully assessed for risks and thoughtfully designed for use among a younger audience.

Share: Considering psychedelic therapy for adolescents


Already Registered?

If you already registered for the in-person portion of the Psychedelic Science 2023 conference, get immediate access to PS2023: The Virtual Trip by logging in with the email address you used when signing up for the conference. We’ll email you a login link—no password necessary!

Need to Register?

If you are not yet registered for Psychedelic Science 2023, you can sign up for PS2023: The Virtual Trip access by creating an account.

Report an Error

The PS2023: The Virtual Trip team has worked hard to create session captions, transcripts, and web pages as accurately as possible, but we know that some errors may have made it past our review process. Let us know what needs to be fixed! Please provide the session name and/or page URL where you found the error, the time the error occurs (if in a video), and the correct information we should use to fix the error. We appreciate your help in making PS2023: The Virtual Trip even better!

This field is for validation purposes and should be left unchanged.